Caveolin-1 influences vascular protease activity and is a potential stabilizing factor in human atherosclerotic disease.

Symptomatic patients presenting with transient ischemic attack or stroke had lower Cav-1 levels than asymptomatic patients but this difference did not reach statistical significance ( Table 3 ; p = 0.13).

also in 111,027 other papers